PHILADELPHIA, PA — Century Therapeutics, Inc. (NASDAQ: IPSC) has announced key leadership changes with the appointments of Morgan Conn, Ph.D., as Chief Financial Officer and Chad Cowan, Ph.D., as Chief Scientific Officer. These appointments are set to take effect on October 14, 2024, and October 1, 2024, respectively, with both joining the company’s Executive Committee. Additionally, Hy Levitsky, M.D., will transition from his operational role as President of Research and Development to an advisory position.
Morgan Conn brings over two decades of experience in financing and strategic roles within the biopharmaceutical industry. His career highlights include serving as Chief Business Officer at Pharvaris and founding CallisBio, a consultancy for corporate strategy. Conn’s academic foundation includes a Ph.D. in Organic Chemistry from MIT and a B.Sc. in Chemistry and Biochemistry from the University of Toronto.
Chad Cowan is recognized for his pioneering work in stem and cell therapy. Before joining Century as an executive scientific advisor, Cowan founded Clade Therapeutics, CRISPR Therapeutics, and held significant roles at Sana Biotechnology. His academic contributions include his tenure at the Broad Institute and Harvard Stem Cell Institute. Cowan’s research has been pivotal in advancing cell therapies, earning him accolades such as the NIH Transformative Research Award.
Hy Levitsky’s departure from daily operational duties marks the end of a significant era for Century. His leadership has been instrumental in steering the company’s research and development initiatives. Levitsky’s continued advisory role underscores his ongoing commitment to the company’s innovative trajectory.
These leadership movements come as Century Therapeutics advances its clinical programs and expands into new therapeutic areas, leveraging its iPSC-derived platform to enhance its pipeline and technological capabilities. The appointments of Conn and Cowan are poised to fortify Century’s strategic direction and scientific leadership in the competitive field of cell therapy.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.